CLINDAMYCIN INJECTION IN 5% DEXTROSE
BAXTER CORPORATION
Quick answers
Is there a shortage of CLINDAMYCIN INJECTION IN 5% DEXTROSE in Canada?
No. There is no current shortage of CLINDAMYCIN INJECTION IN 5% DEXTROSE 900MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
DALACIN C PHOSPHATE
PFIZER CANADA ULC
CLINDAMYCIN INJECTION, USP
ABBOTT LABORATORIES, LIMITED
CLINDAMYCIN INJECTION USP
SANDOZ CANADA INCORPORATED
CLINDAMYCIN IV INFUSION
SANDOZ CANADA INCORPORATED
CLINDAMYCIN INJECTION SDZ
SANDOZ CANADA INCORPORATED
CLINDAMYCIN INJECTION IN 5% DEXTROSE
BAXTER CORPORATION
DIN
02485486
Strength
900MG
Dosage Form
Solution
Route
Intravenous
Active Ingredient
CLINDAMYCIN (CLINDAMYCIN PHOSPHATE)
See all CLINDAMYCIN (CLINDAMYCIN PHOSPHATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from BAXTER CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 00438014
DIN 00786292
DIN 00438049
DIN 00786209
DIN 00437999
DIN 00786217
DIN 00438030
DIN 00438022
DIN 00438006
DIN 00828602
900MG · DIN 00060208
900MG · DIN 00786160